Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control-Reference-Cited by-同舟云学术

Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control

Published:2017-06-23 Issue:10 Volume:45 Page:1049-1059
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Hariparsad Niresh,Ramsden Diane,Palamanda Jairam,Dekeyser Joshua G.,Fahmi Odette A.,Kenny Jane R.,Einolf Heidi,Mohutsky Michael,Pardon Magalie,Siu Y. Amy,Chen Liangfu,Sinz Michael,Jones Barry,Walsky Robert,Dallas Shannon,Balani Suresh K.,Zhang George,Buckley David,Tweedie Donald

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference100 articles.

1. Oxymorphone Extended Release Does Not Affect CYP2C9 or CYP3A4 Metabolic Pathways

2. REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION

3. Evaluation of 309 molecules as inducers of CYP3A4, CYP2B6, CYP1A2, OATP1B1, OCT1, MDR1, MRP2, MRP3 and BCRP in cryopreserved human hepatocytes in sandwich culture;Badolo;Xenobiotica,2015

4. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

5. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic;Drug Metabolism Reviews;2024-07-26

2. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

3. Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin;Pharmaceutics;2023-10-18

4. Regulatory Considerations in Metabolism‐ and Transport‐Based Drug Interactions;Oral Bioavailability and Drug Delivery;2023-10-10

5. Dicloxacillin‐warfarin drug–drug interaction—A register‐based study and in vitro investigations in 3D spheroid primary human hepatocytes;British Journal of Clinical Pharmacology;2023-04-26